References
Chen Q, Wang S, Lang JH (2021) Clinical characteristics and prognostic factors of stage IC ovarian clear cell carcinoma: a surveillance, epidemiology, and end results (SEER) analysis. Arch Gynecol Obstet 21(1):322
Boakye EA, Jenkins WD, Osazuwa-Peters N, Wang M, Lee MJ, Chen B et al (2019) Incidence of second primary neoplasms among cancer survivors in the United States, 2000 through 2015. J Clin Oncol 37:1586–1586
Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: incidence—SEER 9 Regs Research Data, Nov 2020 Sub (1975–2018) <Katrina/Rita Population Adjustment>—linked to county attributes—total U.S., 1969–2019 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2021, based on the November 2020 submission
Funding
The authors have not disclosed any funding.
Author information
Authors and Affiliations
Contributions
HYL: protocol development. YRW: data collection, data analysis, manuscript writing. YG: protocol development, data analysis.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Wang, Y., Guo, Y. & Li, H. Trends in the risk of second primary malignancies among survivors of ovarian clear cell carcinoma. Arch Gynecol Obstet 305, 1641–1643 (2022). https://doi.org/10.1007/s00404-022-06422-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-022-06422-6